China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Summary of cases treated with targeted therapy combined with radioactive iodine-131 for advanced poorly differentiated and undifferentiated thyroid cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136688
Registration Time: 2026/11/13
Type: Observational study
Primary Sponsor: Shanxi Bethune Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=353354
Published by HT Digital Content Services with permission from Health Daily Digest....